Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$2.87M Buy
16,500
+2,100
+15% +$372K 0.13% 189
2017
Q3
$2.69M Sell
14,400
-1,600
-10% -$283K 0.14% 166
2017
Q2
$2.76M Buy
16,000
+4,500
+39% +$732K 0.15% 170
2017
Q1
$1.89M Sell
11,500
-4,500
-28% -$748K 0.09% 234
2016
Q4
$2.34M Sell
16,000
-1,000
-6% -$151K 0.09% 208
2016
Q3
$2.84M Sell
17,000
-4,000
-19% -$676K 0.09% 256
2016
Q2
$3.19M Sell
21,000
-3,000
-13% -$466K 0.1% 235
2016
Q1
$3.6M Hold
24,000
0.1% 204
2015
Q4
$3.9M Hold
24,000
0.12% 188
2015
Q3
$3.32M Sell
24,000
-14,925
-38% -$2.35M 0.09% 227
2015
Q2
$5.98M Buy
38,925
+22,513
+137% +$3.61M 0.15% 157
2015
Q1
$2.62M Sell
16,412
-2,873
-15% -$452K 0.09% 221
2014
Q4
$3.07M Sell
19,285
-26,478
-58% -$4.13M 0.09% 206
2014
Q3
$6.43M Buy
45,763
+34,339
+301% +$4.48M 0.15% 182
2014
Q2
$1.35M Sell
11,424
-33,275
-74% -$3.85M 0.03% 293
2014
Q1
$5.51M Buy
+44,699
New +$5.42M 0.11% 188
2013
Q3
Sell
-7,952
Closed -$785K 173
2013
Q2
$785K Buy
+7,952
New +$825K 0.03% 229

Other funds holding AMGN

GLG Partners's AMGN Position: Q4 2017 in Review

GLG Partners increased its Amgen (AMGN) stake by 15% in Q4 2017, buying an estimated $372K and bringing the position to 16,500 shares worth $2.87M. The position accounts for 0.13% of the portfolio, ranked #189.

GLG Partners first reported a position in AMGN in Q2 2013 and has held it in 17 quarters since. The position peaked at $6.43M in Q3 2014. 1,735 funds tracked by Wall St. Rank hold AMGN as of Q4 2017.

  • GLG Partners held 16,500 shares of Amgen worth $2.87M as of Q4 2017.
  • GLG Partners bought 2,100 Amgen shares in Q4 2017, an estimated $372K.
  • Amgen made up 0.13% of GLG Partners's portfolio in Q4 2017, its #189 holding.
  • GLG Partners first reported a position in Amgen in Q2 2013 and has held it in 17 quarters since.
  • GLG Partners's Amgen position peaked at $6.43M in Q3 2014.
  • 1,735 funds tracked by Wall St. Rank held Amgen as of Q4 2017.

Based on GLG Partners's 13F filing for Q4 2017, filed 14 Feb 2018.